월경통 치료 시장 규모, 점유율 및 성장 분석 : 치료법별, 질환별, 투여 경로별, 최종사용자별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global Dysmenorrhea Treatment Market size was valued at USD 5.84 Billion in 2024 and is poised to grow from USD 6.08 Billion in 2025 to USD 8.4 Billion by 2033, growing at a CAGR of 4.1% during the forecast period (2026-2033).

The dysmenorrhea treatment market is significantly propelled by the growing clinical acknowledgment of menstrual pain as a manageable condition rather than an inevitable discomfort. This sector includes pharmaceuticals, intrauterine devices, non-pharmacologic therapies, and digital health solutions designed for both primary and secondary dysmenorrhea management. While traditional treatment has relied on NSAIDs and combined oral contraceptives, advancements in research and heightened patient advocacy are transitioning focus toward targeted agents and innovative hormone delivery systems. Increasing investments in women's health and integrated care are facilitating the development of new products and enhancing adoption rates. Additionally, AI is revolutionizing personalized treatment strategies by improving diagnostic accuracy and enabling tailored management plans, thus fostering market growth and better patient outcomes across a diverse demographic.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dysmenorrhea Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dysmenorrhea Treatment Market Segments Analysis

Global dysmenorrhea treatment market is segmented by treatment type, condition type, route of administration, end-user, distribution channel and region. Based on treatment type, the market is segmented into Hormonal Therapy, Non-Steroidal Anti-Inflammatory Drugs, Alternative Therapies and Supplements, Surgical Interventions and Others. Based on condition type, the market is segmented into Primary Dysmenorrhea, Secondary Dysmenorrhea and Others. Based on route of administration, the market is segmented into Oral, Injectable, Transdermal Patches and Others. Based on end-user, the market is segmented into Hospitals and Gynecology Clinics, Homecare Settings and Others. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and E-commerce and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Dysmenorrhea Treatment Market

The global market for dysmenorrhea treatment is significantly driven by heightened awareness and education regarding the condition among both healthcare providers and patients. This increased understanding helps in recognizing symptoms and underscores the necessity for treatment, which in turn promotes proactive healthcare-seeking behaviors and the acceptance of various therapeutic options. Enhanced diagnostic pathways and educational initiatives play a crucial role in diminishing stigma and fostering open discussions about dysmenorrhea, leading to greater utilization of prescribed treatments. As knowledge of available solutions proliferates, the demand for effective therapies grows, spurring investments in research, distribution, and awareness efforts that contribute to market growth and improved access to care.

Restraints in the Global Dysmenorrhea Treatment Market

The Global Dysmenorrhea Treatment market faces significant constraints due to inconsistent access to gynecological specialists and specialized treatment facilities. This issue is particularly pronounced in underserved or rural areas where timely diagnosis and the initiation of effective treatment are hindered. In situations where primary care providers lack the expertise or resources to handle more complex cases, patients often miss out on personalized interventions, which diminishes the utilization of existing treatment options. Additionally, geographic and logistical challenges tend to lead patients toward self-managing their symptoms rather than receiving clinician-directed care, thus impeding the market's growth and the adoption of innovative therapies.

Market Trends of the Global Dysmenorrhea Treatment Market

The Global Dysmenorrhea Treatment market is experiencing a notable trend towards digital care integration, driven by the increasing adoption of telehealth platforms and symptom tracking applications. This shift enhances patient engagement and ensures continuity of care through virtual consultations and remote monitoring solutions. By emphasizing digital triage and personalized treatment pathways, healthcare providers are facilitating early intervention and improving patient outcomes. Tools that facilitate symptom recognition and adherence support are essential in lowering barriers to specialist access, while integration with electronic health records promotes coordinated treatment strategies. Overall, this digital transformation is paving the way for better education and management of dysmenorrhea.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Dysmenorrhea Treatment Market Size by Treatment Type & CAGR (2026-2033)

• Market Overview
• Hormonal Therapy
  • Combined Oral Contraceptives
  • Progestin-only Pills
• Non-Steroidal Anti-Inflammatory Drugs
• Alternative Therapies and Supplements
• Surgical Interventions
• Others

Global Dysmenorrhea Treatment Market Size by Condition Type & CAGR (2026-2033)

• Market Overview
• Primary Dysmenorrhea
• Secondary Dysmenorrhea
• Others

Global Dysmenorrhea Treatment Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Injectable
• Transdermal Patches
• Others

Global Dysmenorrhea Treatment Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals and Gynecology Clinics
• Homecare Settings
• Others

Global Dysmenorrhea Treatment Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies and E-commerce
• Others

Global Dysmenorrhea Treatment Market Size & CAGR (2026-2033)

• North America (Treatment Type, Condition Type, Route of Administration, End-User, Distribution Channel)
  • US
  • Canada
• Europe (Treatment Type, Condition Type, Route of Administration, End-User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Type, Condition Type, Route of Administration, End-User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Type, Condition Type, Route of Administration, End-User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Type, Condition Type, Route of Administration, End-User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Bayer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (GSK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Lifesciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alkem Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Torrent Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mankind Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Assertio Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perrigo
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations